Viramal

Women’s Health Innovation
Viramal Announces Key Appointments
150 150 Administrator

– Angela Rossetti Appointed Chairman – – Alexandra Pearce Appointed Chief Operating Officer and Head of Regulatory Affairs – NEW YORK, June 8, 2017 /PRNewswire/ — Viramal, (“the Company”), an emerging specialty pharmaceutical company developing therapeutics that improve the quality of women’s health, today announced the appointment of Ms. Angela Rossetti, as Chairman and Dr. Alexandra…

read more
Viramal to Present at the BIO International Convention in San Francisco
150 150 Administrator

NEW YORK, May 25, 2016 /PRNewswire/ — Viramal, (“the Company”), an emerging specialty pharmaceutical company developing therapeutics that improve the quality of women’s health, today announced that the Company’s CEO, Oliver Bates, will present at the 2016 BIO International Convention in San Francisco. The presentation will take place on Tuesday, June 7, 2016 at 3:15 p.m.…

read more
Viramal Appoints Experienced Pharmaceutical Executive, Angela Rossetti, to Board of Directors
150 150 Administrator

 Viramal Appoints Experienced Pharmaceutical Executive, Angela Rossetti, to Board of Directors NEW YORK, May 18, 2016 /PRNewswire/ — Viramal, (“the Company”), an emerging specialty pharmaceutical company developing therapeutics that improve the quality of women’s health, today announced the appointment of Angela Rossetti to its Board of Directors, effective immediately. Ms. Rossetti is a highly qualified corporate…

read more
Viramal Featured in Key Industry Publication
150 150 Administrator

Viramal seeks CROs for men’s and women’s health trials in 2016, global or US partner for TestoCream – exec Viramal is open to contact from CROs and CMOs for a number of men’s and women’s health products with clinical trials initiating in 2016, said CEO Oliver Bates. The company is also searching for a global…

read more
Vio CEO Presentation
Viramal Presentation at BIO CEO & Investor Conference
1024 723 Administrator

CLICK TO VIEW OR DOWNLOAD THE PRESENTATION

read more
Viramal to Present at the 18th Annual BIO CEO & Investor Conference
150 150 Administrator

NEW YORK, February 3, 2016 /PRNewswire/ — Viramal, (“the Company”), an emerging specialty pharmaceutical company developing therapeutics that improve the quality of women’s health, today announced that the Company’s CEO, Oliver Bates, will present at the 18th Annual BIO CEO & Investor Conference. The presentation will take place on Monday, February 8, 2016 at 4:00 p.m.…

read more
Viramal Appoints Women’s Healthcare Expert, William Bologna, as Chairman of the Board of Directors
150 150 Administrator

NEW YORK, February 2, 2016 – Viramal, (“the Company”), an emerging specialty pharmaceutical company developing therapeutics that improve the quality of women’s health, today announced the appointment of William Bologna as Chairman of the Board of Directors, effective immediately. Mr. Bologna is also the Company’s chief scientist. Bill Bologna is a pioneer in women’s healthcare who…

read more